Visionary Wealth Advisors Oncternal Therapeutics, Inc. Transaction History

Visionary Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$1.37 - $2.43 $13,837 - $24,543	10,100 New	10,100 $14,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $4.39 $41,995 - $81,215	-18,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.37 - $4.76 $1,011 - $1,428	300 Added 1.65%	18,500 $77,000
Q2 2021 Aug 13, 2021	BUY	$4.75 - $9.39 $86,450 - $170,898	18,200 New	18,200 $86,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Visionary Wealth Advisors with notifications on news.